Boston Scientific Announces Results for First Quarter 2024
PremiumPress ReleasesBoston Scientific Announces Results for First Quarter 2024
5M ago
Axonics shareholders approve merger with Boston Scientific
Premium
The Fly
Axonics shareholders approve merger with Boston Scientific
6M ago
Axonics provides update on inter partes review proceedings
Premium
The Fly
Axonics provides update on inter partes review proceedings
6M ago
Axonics reports Q4 EPS 13c, consensus 6c
PremiumThe FlyAxonics reports Q4 EPS 13c, consensus 6c
7M ago
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Premium
Press Releases
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
8M ago
Boston Scientific price target raised to $70 from $62 at Wells Fargo
Premium
The Fly
Boston Scientific price target raised to $70 from $62 at Wells Fargo
8M ago
Axonics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyAxonics downgraded to Neutral from Overweight at Piper Sandler
8M ago
Axonics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Axonics downgraded to Market Perform from Outperform at Leerink
8M ago
Axonics downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Axonics downgraded to Equal Weight from Overweight at Wells Fargo
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100